Detalhe da pesquisa
1.
Cancer-associated polybromo-1 bromodomain 4 missense variants variably impact bromodomain ligand binding and cell growth suppression.
J Biol Chem
; 300(4): 107146, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38460939
2.
Current Trends in Sirtuin Activator and Inhibitor Development.
Molecules
; 29(5)2024 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38474697
3.
Development of activity-based probes for the protein deacylase Sirt1.
Bioorg Chem
; 104: 104232, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32911193
4.
Oral and Inhaled Fosamprenavir Reverses Pepsin-Induced Damage in a Laryngopharyngeal Reflux Mouse Model.
Laryngoscope
; 133 Suppl 1: S1-S11, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35678265
5.
Selective and Cell-Active PBRM1 Bromodomain Inhibitors Discovered through NMR Fragment Screening.
J Med Chem
; 65(20): 13714-13735, 2022 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36227159
6.
Covalent-Fragment Screening of BRD4 Identifies a Ligandable Site Orthogonal to the Acetyl-Lysine Binding Sites.
ACS Chem Biol
; 15(4): 1036-1049, 2020 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32149490